pyrazolanthrone has been researched along with Fatty Liver, Nonalcoholic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kato, H; Morishita, S; Murakoshi, M; Nishino, H; Ono, T; Saito, K; Sugiyama, K; Tomita, K | 1 |
| Alarcón-Vila, C; Baulies, A; Caballeria, J; Casas, J; Elena, M; Fabriàs, G; Fernandez-Checa, JC; García-Ruiz, C; Martínez, L; Torres, S | 1 |
| Harrison-Findik, DD; Kharbanda, KK; Lu, S; Mott, JL; Natarajan, SK | 1 |
| Gao, Y; Yan, H; Zhang, Y | 1 |
4 other study(ies) available for pyrazolanthrone and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Lactoferrin attenuates fatty acid-induced lipotoxicity via Akt signaling in hepatocarcinoma cells.
Topics: Animals; Anthracenes; Apoptosis; Benzimidazoles; Cattle; Fatty Acids, Nonesterified; Hep G2 Cells; Humans; JNK Mitogen-Activated Protein Kinases; Lactoferrin; Lipid Metabolism; Lipotropic Agents; Liver; MAP Kinase Signaling System; Non-alcoholic Fatty Liver Disease; Peptide Fragments; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Quinoxalines | 2015 |
Myristic acid potentiates palmitic acid-induced lipotoxicity and steatohepatitis associated with lipodystrophy by sustaning de novo ceramide synthesis.
Topics: Animals; Anthracenes; Apoptosis; Ceramides; Cholesterol; Disease Models, Animal; Endoplasmic Reticulum Stress; Fatty Acids, Monounsaturated; Hepatocytes; JNK Mitogen-Activated Protein Kinases; Lipodystrophy; Liver; Male; Mice, Inbred C57BL; Mice, Knockout; Mitochondria, Liver; Myristic Acid; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Oxidoreductases; Palmitic Acid; Protein Kinase Inhibitors; Reactive Oxygen Species; Ruthenium Red; Sphingosine N-Acyltransferase; Time Factors | 2015 |
Ceramide Induces Human Hepcidin Gene Transcription through JAK/STAT3 Pathway.
Topics: Anthracenes; Ceramides; Chromatin Immunoprecipitation; Dactinomycin; Hep G2 Cells; Hepcidins; Humans; Iron; Janus Kinases; Liver; Mutagenesis, Site-Directed; NF-kappa B; Non-alcoholic Fatty Liver Disease; Obesity; Phosphorylation; Prevalence; Promoter Regions, Genetic; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Recombinant Fusion Proteins; Response Elements; RNA Interference; RNA, Messenger; RNA, Small Interfering; Signal Transduction; STAT3 Transcription Factor; Transcription, Genetic | 2016 |
Inhibition of JNK suppresses autophagy and attenuates insulin resistance in a rat model of nonalcoholic fatty liver disease.
Topics: Animals; Anthracenes; Autophagy; Diet, High-Fat; Insulin Resistance; Liver; Male; Mitogen-Activated Protein Kinase 8; Non-alcoholic Fatty Liver Disease; Protein Kinase Inhibitors; Rats, Sprague-Dawley | 2017 |